If you are experiencing problems downloading PDF or HTML fulltext, our helpdesk recommend clearing your browser cache and trying again. If you need help in clearing your cache, please click here . Still need help? Email help@ingentaconnect.com

The hepatitis C virus enigma

$48.00 plus tax (Refund Policy)

Download / Buy Article:

Abstract:

Myrmel H, Ulvestad E, Åsjø B. The hepatitis C virus enigma. APMIS 2009; 117: 427–39.

Hepatitis C virus (HCV) has a high propensity to establish chronic infection with end-stage liver disease. The high turnover of virus particles and high transcription error rates due to lack of proof-reading function of the viral polymerase imply that HCV exists as quasispecies, thus enabling the virus to evade the host immune response. Clearance of the virus is characterized by a multispecific, vigorous and persistent T-cell response, whereas T-cell responses are weak, narrow and transient in patients who develop chronic infection. At present, standard treatment is a combination of pegylated interferon-α and ribavirin, with a sustained viral response rate of 40–80%, depending on genotype. The mechanisms for the observed synergistic effects of the two drugs are still not known in detail, but in addition to direct antiviral mechanisms, the immunomodulatory effects of both drugs seem to be important, with a shift from Th2- to Th1-cytokine profiles in successfully treated patients. This article describes virus–host relations in the natural course of HCV infection and during treatment.

Keywords: Hepatitis; immunology; variability; virus

Document Type: Research Article

DOI: http://dx.doi.org/10.1111/j.1600-0463.2009.02454.x

Affiliations: Department of Microbiology and Immunology, Haukeland University Hospital; and

Publication date: May 1, 2009

Related content

Tools

Favourites

Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more